ACAD

NASDAQStock

ACADIA Pharmaceuticals Inc.

$21.33-0.65 (-2.96%)

52-Week Range

$14.10
$28.06

Key Stats

Market Cap

3.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Volume

744.9K

Avg Volume

2.0M

Performance

1M

-6.30%

3M

-21.66%

6M

-13.78%

YTD

-19.09%

1Y

+26.83%

3Y

+9.58%

5Y

-29.08%

Price Chart

ETF Exposure

ACAD is held by 136 ETFs

ETFFund NameWeight
IBRNiShares Neuroscience and Healthcare ETF3.30%
FBTFirst Trust NYSE Arca Biotechnology Index Fund3.01%
PBEInvesco Biotechnology & Genome ETF2.62%
SBIOALPS Medical Breakthroughs ETF2.45%
MNTLTema Neuroscience And Mental Health ETF2.42%
ASCEAllspring SMID Core ETF1.86%
PSCHInvesco S&P SmallCap Health Care ETF1.71%
BBPVirtus Biotech ETF1.27%
RZGInvesco S&P SmallCap 600 Pure Growth ETF1.21%
GRPZInvesco S&P SmallCap 600 GARP ETF1.06%
XBIState Street SPDR S&P Biotech ETF0.94%
FSMLFranklin Small Cap Enhanced ETF0.89%
ROSCHartford Multifactor Small Cap ETF0.63%
XSHQInvesco S&P SmallCap Quality ETF0.62%
FNYFirst Trust Mid Cap Growth AlphaDEX Fund0.61%
ACSGAmerican Century Small Cap Growth Insights ETF0.47%
FLQSFranklin U.S. Small Cap Multifactor Index ETF0.45%
VIOGVanguard S&P Small-Cap 600 Growth ETF0.40%
AGNGGlobal X - Aging Population ETF0.39%
IJTiShares S&P Small-Cap 600 Growth ETF0.37%
SLYGState Street SPDR S&P 600 Small Cap Growth ETF0.36%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.35%
SQLVRoyce Quant Small-Cap Quality Value ETF0.33%
HEAL.LiShares Healthcare Innovation UCITS ETF0.33%
IBBiShares Biotechnology ETF0.33%
VFQYVanguard U.S. Quality Factor ETF0.30%
ESIXState Street SPDR S&P SmallCap 600 ESG ETF0.29%
IBBQInvesco Nasdaq Biotechnology ETF0.29%
FNXFirst Trust Mid Cap Core AlphaDEX Fund0.24%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.24%
USVMVictoryShares US Small Mid Cap Value Momentum ETF0.24%
BFORBarron's 400SM ETF0.22%
IWOiShares Russell 2000 Growth ETF0.22%
XJRiShares ESG Select Screened S&P Small-Cap ETF0.22%
PWSPacer WealthShield ETF0.22%
VIOOVanguard S&P Small-Cap 600 ETF0.20%
QVMSInvesco S&P SmallCap 600 QVM Multi-factor ETF0.20%
BIBProShares - Ultra Nasdaq Biotechnology0.20%
VTWGVanguard Russell 2000 Growth ETF0.20%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF0.20%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.19%
FADFirst Trust Multi Cap Growth AlphaDEX Fund0.19%
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETF0.19%
IJRiShares Core S&P Small-Cap ETF0.18%
LNGRGlobal X Aging Population ETF0.18%
BKSEBNY Mellon US Small Cap Core Equity ETF0.18%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF0.16%
DFASDimensional - US Small Cap ETF0.16%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.15%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.14%
Page 1 of 3Next

About ACAD ETF Exposure

ACADIA Pharmaceuticals Inc. (ACAD) is held by 136 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.6B, ACAD is a widely held institutional stock. The stock currently trades at $21.33. Investors can gain exposure to ACAD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACAD, sorted by portfolio weight.